Avadel Pharmaceuticals said its once-nightly narcolepsy drug Lumryz can now be used to treat children older than 7 years of age.
READ MOREValneva is eyeing a 2027 launch for its Pfizer-partnered Lyme disease vaccine, CEO Thomas Lingelbach said Thursday during the company’s investor day.
READ MOREFDA officials, including the directors of CBER and CDER, on Wednesday launched a rare disease innovation hub at a public meeting, with an aim to better collaborate and communicate across ...
READ MOREMerck KGaA said its doors are open for more M&A, particularly for its manufacturing business, as the company tempers sales expectations for its life science arm due to a muted market in ...
READ MORE